| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
2 companies
Regnante Keith is a Chief Financial Officer at Keros Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $723K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2023 | KROS Keros Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 40,000 | $45.29 | $1,811,600.00 | -100% | +66.0% | +87.7% | |
| Jun 9, 2023 | KROS Keros Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 40,000 | $46.61 | $1,864,239.43 | -81.2% | -18.5% | +10.9% | |
| Feb 19, 2019 | WVE Wave Life Sciences Ltd. | Chief Financial Officer | Sell | 1,298 | $36.84 | $47,817.80 | -7.6% | - | - | |
| Sep 24, 2018 | WVE Wave Life Sciences Ltd. | Chief Financial Officer | Sale+OE | 29,500 | $55.00 | $1,622,500.00 | -63.5% | - | - | |
| Feb 16, 2018 | WVE Wave Life Sciences Ltd. | Chief Financial Officer | Sell | 316 | $51.85 | $16,384.60 | -1.8% | - | - |